IWS
GILD icon

Insight Wealth Strategies’s Gilead Sciences GILD Stock Holding History

Insight Wealth Strategies’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-24,412
Closed -$1.98M – 169
2023
Q4 		$1.98M Buy
24,412
+962
+4% +$74.9K 0.32% 71
2023
Q3 		$1.76M Buy
23,450
+1,931
+9% +$149K 0.34% 59
2023
Q2 		$1.66M Sell
21,519
-483
-2% -$38.5K 0.32% 55
2023
Q1 		$1.83M Sell
22,002
-3,514
-14% -$291K 0.36% 45
2022
Q4 		$2.19M Buy
25,516
+661
+3% +$52.3K 0.42% 31
2022
Q3 		$1.54M Hold
24,855
– – 0.29% 53
2022
Q2 		$1.54M Buy
+24,855
New +$1.54M 0.29% 53

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Insight Wealth Strategies's GILD Position: Q1 2024 in Review

Insight Wealth Strategies sold out of Gilead Sciences (GILD) in Q1 2024, closing a stake of 24,412 shares — an estimated $1.98M sold.

Insight Wealth Strategies first reported a position in GILD in Q2 2022 and held it in 7 quarters. The position peaked at $2.19M in Q4 2022. 1,722 funds tracked by Wall St. Rank hold GILD as of Q1 2024.

  • Insight Wealth Strategies reported no remaining Gilead Sciences position as of Q1 2024 after selling out during the quarter.
  • Insight Wealth Strategies sold 24,412 Gilead Sciences shares in Q1 2024, an estimated $1.98M.
  • Insight Wealth Strategies first reported a position in Gilead Sciences in Q2 2022 and held it in 7 quarters.
  • Insight Wealth Strategies's Gilead Sciences position peaked at $2.19M in Q4 2022.
  • 1,722 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2024.

Based on Insight Wealth Strategies's 13F filing for Q1 2024, filed 5 Apr 2024.